NovoCure GmbH
Quick facts
Phase 3 pipeline
- Immune checkpoint inhibitors or docetaxel · Oncology
This is a combination approach using immune checkpoint inhibitors to enhance anti-tumor immunity and/or docetaxel chemotherapy to directly kill cancer cells.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: